Buprenorphine for Pain in the Setting of Terminal Disease – MCBAP, CME & Social Work CEU Credits Approved (DEA Training)

Please join us for a presentation and discussion on understanding pharmacodynamics and the mechanism of buprenorphine in patients with a terminal disease. This webinar will present available evidence on buprenorphine for chronic pain and malignant pain and give practical guidance for pain management using buprenorphine. Q&A and discussion to follow.

1 Available Credit – Meets DEA SUD Training Requirements:

• MCBAP credit approved
• CME credit approved
• Social Work CEU credit approved

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MyMichigan Health and Michigan Opioid Collaborative. MyMichigan Health is accredited by the Michigan State Medical Society to provide continuing medical education for physicians. MyMichigan Health designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity. This training meets the new DEA SUD training requirements.

Presenter:

• Dr. Jane Chargot

Register Here:

Click here or scan the QR Code below to register for this webinar!

We hope to see you there!

Want to share this event? Download our flyer for this event and pass it along.